Immuneering (IMRX) Institutional Ownership → Elon to Transform U.S. Economy? (From Porter & Company) (Ad) Free IMRX Stock Alerts $1.47 -0.07 (-4.55%) (As of 05/17/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Immuneering (NASDAQ:IMRX)CurrentInstitutional OwnershipPercentage67.65%Number ofInstitutional Buyers(last 12 months)14TotalInstitutional Inflows(last 12 months)$31.34MNumber ofInstitutional Sellers(last 12 months)4TotalInstitutional Outflows(last 12 months)$8.16M Get IMRX Insider Trade Alerts Want to know when executives and insiders are buying or selling Immuneering stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data IMRX Institutional Buying and Selling by Quarter Ad TradingTipsFree report reveals “two-baggers” for 2024We’ve put together something special for our subscribers — a free report on 5 stocks we believe could double in 2024. It’s straightforward, easy to understand, and most importantly, actionable.Download your free report today! Immuneering Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/15/2024 Price T Rowe Associates Inc. MD910,266$2.63M0.0%-73.1%3.070% 5/10/2024 Vanguard Group Inc.1,203,666$3.48M0.0%+12.1%4.060% 2/12/2024 TD Asset Management Inc197,876$1.45M0.0%-30.4%0.676% 1/5/2024 Exchange Traded Concepts LLC17,416$128K0.0%+34.0%0.060% 11/15/2023 Adage Capital Partners GP L.L.C.195,000$1.50M0.0%+11.4%0.666% 11/14/2023 Corton Capital Inc.18,847$145K0.1%N/A0.064% Get the Latest News and Ratings for IMRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Immuneering and its competitors with MarketBeat's FREE daily newsletter. 11/13/2023 Southport Management L.L.C.17,500$134K0.7%N/A0.060% 11/13/2023 FMR LLC612,168$4.70M0.0%-7.0%2.092% 11/13/2023 PNC Financial Services Group Inc.20,000$154K0.0%N/A0.068% 10/27/2023 TD Asset Management Inc284,476$2.19M0.0%+100.0%0.972% 10/18/2023 Exchange Traded Concepts LLC12,999$100K0.0%-12.7%0.044% 9/8/2023Tucker Asset Management LLC11,036$112K0.0%N/A0.038% 8/15/2023 HighVista Strategies LLC253,110$2.57M1.2%N/A0.865% 8/14/2023 Cormorant Asset Management LP4,204,364$42.63M2.4%+76.2%14.369% 8/11/2023 ExodusPoint Capital Management LP127,719$1.30M0.0%+48.0%0.436% 8/9/2023 TD Asset Management Inc142,238$1.44M0.0%-1.3%0.486% 8/4/2023 American International Group Inc.9,761$99K0.0%N/A0.033% 8/2/2023 Bank of Montreal Can714,037$8.00M0.0%N/A2.441% 7/26/2023 Janney Montgomery Scott LLC22,135$224K0.0%N/A0.076% 7/20/2023 Exchange Traded Concepts LLC14,884$151K0.0%N/A0.051% 5/11/2023 ExodusPoint Capital Management LP86,297$838K0.0%N/A0.295% 5/9/2023 Y Intercept Hong Kong Ltd11,114$108K0.0%N/A0.038% 11/15/2022 Citadel Advisors LLC2,184,909$31.29M0.0%-0.7%8.273% 8/4/2022 TD Asset Management Inc.147,661$799K0.0%+21.8%0.560% 5/10/2022 TD Asset Management Inc.121,201$784K0.0%+253.4%0.459% 2/15/2022 Adage Capital Partners GP L.L.C.314,000$5.08M0.0%N/A1.210% 2/14/2022 Citadel Advisors LLC2,058,102$32.04M0.0%+0.1%7.934% 2/8/2022 Northern Trust Corp75,891$1.23M0.0%+4.5%0.293% 2/2/2022 New York State Common Retirement Fund4,637$75K0.0%+172.8%0.018% 1/28/2022 Allspring Global Investments Holdings LLC9,228$149K0.0%N/A0.036% 12/3/2021 Perceptive Advisors LLC681,051$18.08M0.3%N/A2.625% 11/16/2021 Suvretta Capital Management LLC200,000$5.31M0.1%N/A0.771% 11/16/2021 Metropolitan Life Insurance Co NY2,814$75K0.0%N/A0.011% 11/16/2021 Millennium Management LLC89,788$2.38M0.0%N/A0.346% 11/16/2021 Citadel Advisors LLC2,055,459$52.40M0.0%N/A7.924% 11/15/2021 Rock Springs Capital Management LP1,089,816$28.94M0.6%N/A4.201% 11/15/2021 Marshall Wace LLP13,149$349K0.0%N/A0.051% 11/15/2021 Caas Capital Management LP40,000$1.06M0.0%N/A0.154% 11/12/2021 Ghisallo Capital Management LLC15,000$398K0.0%N/A0.058% 11/12/2021 Geode Capital Management LLC122,319$3.25M0.0%N/A0.472% You missed the class - here’s your second chance (Ad)It’s time to start your Weekend Side Hustle Right now, some of the HARDEST working folks are getting destroyed by inflation. And that’s left folks looking anywhere they can to generate extra income to cover the bills. It’s almost impossible to keep up with the ever rising costs of living anymore…Click here and I’ll give you the details.11/10/2021 Citigroup Inc.1,246$33K0.0%N/A0.005% 11/9/2021 BlackRock Inc.1,524,374$40.47M0.0%N/A5.877% 11/9/2021 TD Asset Management Inc.34,296$911K0.0%N/A0.132% 11/4/2021 Deutsche Bank AG4,752$126K0.0%N/A0.018% 11/2/2021 New York State Common Retirement Fund1,700$45K0.0%N/A0.007% (Data available from 1/1/2016 forward) IMRX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of IMRX shares? During the previous two years, 19 institutional investors and hedge funds held shares of Immuneering. The most heavily invested institutionals were Cormorant Asset Management LP ($42.63M), Citadel Advisors LLC ($31.29M), Bank of Montreal Can ($8.00M), FMR LLC ($4.70M), Vanguard Group Inc. ($3.48M), Price T Rowe Associates Inc. MD ($2.63M), and HighVista Strategies LLC ($2.57M).Learn more on IMRX's institutional investors. What percentage of Immuneering stock is owned by institutional investors? 67.65% of Immuneering stock is owned by institutional investors. Learn more on IMRX's institutional investor holdings. Which institutional investors have been buying Immuneering stock? Of the 16 institutional investors that purchased Immuneering stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Cormorant Asset Management LP ($1.82M), Bank of Montreal Can ($714.04K), HighVista Strategies LLC ($253.11K), TD Asset Management Inc ($142.24K), Vanguard Group Inc. ($129.85K), ExodusPoint Capital Management LP ($127.72K), and TD Asset Management Inc. ($26.46K). How much institutional buying is happening at Immuneering? Institutional investors have bought a total of 3,361,292 shares in the last 24 months. This purchase volume represents approximately $32.42M in transactions. Which Immuneering major shareholders have been selling company stock? The following institutional investors have sold Immuneering stock in the last 24 months: Price T Rowe Associates Inc. MD ($2.47M), TD Asset Management Inc ($88.47K), FMR LLC ($46.28K), Citadel Advisors LLC ($14.30K), and Exchange Traded Concepts LLC ($1.89K). How much institutional selling is happening at Immuneering? Institutional investors have sold a total of 2,618,760 shares in the last 24 months. This volume of shares sold represents approximately $8.36M in transactions. Related Companies: AADI Major Shareholders CLNN Major Shareholders RMTI Major Shareholders BOLT Major Shareholders NXTC Major Shareholders RVPH Major Shareholders OCUP Major Shareholders HCWB Major Shareholders BLRX Major Shareholders GANX Major Shareholders This page (NASDAQ:IMRX) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersShocking: One AI startup's revenue could surge 4,735%Manward PressShocking $16T Elon Musk Crypto LeakCrypto 101 MediaDems have chosen Biden replacement?Paradigm PressBiden Nomination CANCELED?The Freeport SocietyUrgent Nvidia WarningAltimetryMost important medical advance in 100 yearsThe Oxford ClubMissed NVDA? Buy this AI stock NOWChaikin Analytics41 banks launch ‘crypto dollar’Stansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Immuneering Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.